Vident Investment Advisory’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-38,835
| Closed | -$1.11M | – | 1245 |
|
|
2021
Q3 | $1.11M | Sell |
38,835
-2,774
| -7% | -$79.1K | 0.03% | 641 |
|
|
2021
Q2 | $1.41M | Buy |
41,609
+10,170
| +32% | +$344K | 0.04% | 548 |
|
|
2021
Q1 | $951K | Hold |
31,439
| – | – | 0.03% | 625 |
|
|
2020
Q4 | $1.56M | Buy |
31,439
+1,004
| +3% | +$49.7K | 0.06% | 388 |
|
|
2020
Q3 | $1.17M | Sell |
30,435
-2,030
| -6% | -$77.9K | 0.06% | 446 |
|
|
2020
Q2 | $1.4M | Sell |
32,465
-12,177
| -27% | -$526K | 0.07% | 354 |
|
|
2020
Q1 | $1.17M | Sell |
44,642
-3,168
| -7% | -$82.7K | 0.08% | 342 |
|
|
2019
Q4 | $1.49M | Sell |
47,810
-16,761
| -26% | -$524K | 0.09% | 334 |
|
|
2019
Q3 | $1.68M | Sell |
64,571
-1,845
| -3% | -$48.1K | 0.15% | 101 |
|
|
2019
Q2 | $1.52M | Sell |
66,416
-5,450
| -8% | -$125K | 0.12% | 119 |
|
|
2019
Q1 | $1.88M | Sell |
71,866
-2,355
| -3% | -$61.7K | 0.1% | 298 |
|
|
2018
Q4 | $1.51M | Buy |
+74,221
| New | +$1.51M | 0.08% | 319 |
|